Online citations, reference lists, and bibliographies.
← Back to Search

Retinoids: New Use By Innovative Drug-delivery Systems

E. Trapasso, D. Cosco, C. Celia, M. Fresta, D. Paolino
Published 2009 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Background: Retinoids represent an old class of bioactives used in the treatment of different skin pathologies (such as acne and psoriasis) and in the treatment of many tumors. Unfortunately, they present several side effects, i.e., burning of skin and general malaise after systemic administration and they are very unstable after exposition to light. Methods: One of the most promising new approaches for reducing the side effects of retinoids while improving their pharmacological effect is the use of drug-delivery devices. This review explains the current status of retinoid drug transport, which has been developing over the last few years, explaining the modification of their biopharmaceutical properties in detail after encapsulation/inclusion in vesicular and polymeric systems. Results/conclusion: Different colloidal and micellar systems containing retinoid drugs have been realized furnishing important potential advancements in traditional therapy.
This paper references
10.1517/14656566.9.8.1363
Systemic retinoids in chemoprevention of non-melanoma skin cancer.
M. Lens (2008)
10.1186/1756-9966-27-18
Role of retinoic receptors in lung carcinogenesis
K. Bogos (2008)
A review of systemic retinoid therapy for acne and related conditions.
R. Kunynetz (2004)
10.1016/J.IJPHARM.2007.02.033
All-trans-retinoic acid nanodisks.
Katherine A Redmond (2007)
Liposome-associated retinoids: production and antiproliferative activity on neoplastic cells
R Cortesi (1994)
10.1016/0145-2126(94)90040-X
Liposome encapsulation circumvents the hepatic clearance mechanisms of all-trans-retinoic acid.
K. Mehta (1994)
10.2174/138161206779026245
Polymeric micelles for drug delivery.
S. Croy (2006)
10.1016/S0378-5173(00)00366-5
Investigation on the photostability of a tretinoin lotion and stabilization with additives.
M. Brisaert (2000)
10.1111/j.1529-8019.2006.00082.x
Update on retinoid therapy of psoriasis in: an update on the use of retinoids in dermatology
P. V. D. van de Kerkhof (2006)
10.1101/GAD.13.24.3209
Mechanism of corepressor binding and release from nuclear hormone receptors.
László Kálmán Nagy (1999)
10.1016/J.CANLET.2004.10.016
All-trans retinoic acid inhibits the cell proliferation but enhances the cell invasion through up-regulation of c-met in pancreatic cancer cells.
K. Leelawat (2005)
10.1016/S0304-3835(98)00226-2
Altered metabolism of all-trans-retinoic acid in liposome-encapsulated form.
R. Parthasarathy (1998)
10.1517/13543784.4.7.593
Section Review: Retinoids: Biological Function and Use in the Treatment of Dermatological Diseases: Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis
Marcus F. Boehm (1995)
10.1016/J.IJPHARM.2006.08.007
Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery.
J. Liu (2007)
10.1016/0014-5793(90)80030-M
Liposome‐associated retinoic acid
C. Nastruzzi (1990)
10.1016/0001-8686(95)00242-I
Non-ionic surfactant vesicles (niosomes): Physical and pharmaceutical chemistry
I. Uchegbu (1995)
10.1016/S0378-5173(03)00151-0
Stability and antitumor effects of all-trans retinoic acid-loaded liposomes contained sterylglucoside mixture.
K. Shimizu (2003)
10.1016/J.IJPHARM.2005.01.012
Accelerated photostability study of tretinoin and isotretinoin in liposome formulations.
G. Ioele (2005)
10.1016/j.febslet.2007.11.081
Retinoid metabolism and nuclear receptor responses: New insights into coordinated regulation of the PPAR–RXR complex
O. Ziouzenkova (2008)
10.1016/S1773-2247(08)50061-X
Liposomes for (trans)dermal delivery of tretinoin: influence of drug concentration and vesicle composition
M. Manconi (2008)
10.1016/S0378-5173(02)00269-7
Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid.
Soo-Jeong Lim (2002)
10.1016/S0939-6411(00)00087-4
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
R. Mueller (2000)
10.1016/0928-0987(94)90011-6
Liposome-associated retinoids: production, characterization and antiproliferative activity on neoplastic cells
R. Cortesi (1994)
10.1016/J.JCONREL.2005.10.030
Induction of apoptosis in A549 human lung cancer cells by all-trans retinoic acid incorporated in DOTAP/cholesterol liposomes.
S. Kawakami (2006)
10.1016/J.IJPHARM.2005.11.045
Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin.
M. Manconi (2006)
10.1016/j.ijpharm.2007.12.035
Tretinoin-loaded nanocapsules: Preparation, physicochemical characterization, and photostability study.
A. Ourique (2008)
10.1016/J.JCONREL.2004.11.036
Successful treatment of photo-damaged skin of nano-scale atRA particles using a novel transdermal delivery.
Y. Yamaguchi (2005)
10.1038/sj.onc.1204763
All trans retinoic acid in acute promyelocytic leukemia
L. Degos (2001)
10.1016/S0378-5173(03)00183-2
Particle size of liposomes influences dermal delivery of substances into skin.
D. Verma (2003)
10.1016/S0378-5173(03)00268-0
Niosomes as carriers for tretinoin. II. Influence of vesicular incorporation on tretinoin photostability.
M. Manconi (2003)
10.1016/J.IJPHARM.2006.03.040
Retinol-encapsulated low molecular water-soluble chitosan nanoparticles.
Dong-Gon Kim (2006)
10.1016/B978-0-08-011432-3.50006-X
CHAPTER 1 – PREPARATION AND PROPERTIES
L. C. Schroeter (1966)
10.1182/BLOOD.V94.4.1192.416K07_1192_1200
A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group.
P. Fenaux (1999)
10.1248/CPB.54.242
Enhanced delivery of retinoic acid to skin by cationic liposomes.
S. Kitagawa (2006)
10.1016/S0378-5173(03)00128-5
Development of polymeric nanoparticulate drug delivery systems: evaluation of nanoparticles based on biotinylated poly(ethylene glycol) with sugar moiety.
I. Kim (2003)
Drug Deliv
Cosco (2009)
10.1182/BLOOD-2002-02-0632
All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol.
M. Tallman (2002)
10.1016/J.JCONREL.2006.08.025
Inhibition of pulmonary metastasis in mice by all-trans retinoic acid incorporated in cationic liposomes.
Sachiko Suzuki (2006)
10.1111/J.1529-8019.2006.00082.X
Update on retinoid therapy of psoriasis in: an update on the use of retinoids in dermatology.
P. Kerkhof (2006)
10.1517/17425247.5.7.737
Colloidal carriers for the enhanced delivery through the skin.
D. Cosco (2008)
10.1016/J.IJPHARM.2007.05.061
Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery.
Kumar A. Shah (2007)
10.1016/S0009-2797(02)00204-1
Cytosolic retinoid dehydrogenases govern ubiquitous metabolism of retinol to retinaldehyde followed by tissue-specific metabolism to retinoic acid.
G. Duester (2003)
10.1101/GAD.13.24.3198
Molecular determinants of nuclear receptor-corepressor interaction.
V. Perissi (1999)
10.1016/S0169-409X(01)00209-5
Cell-specific delivery of genes with glycosylated carriers.
M. Hashida (2001)
10.2174/138161207782110534
Prospective teratology of retinoic acid metabolic blocking agents (RAMBAs) and loss of CYP26 activity.
P. McCaffery (2007)
10.1016/J.JCONREL.2004.11.020
Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle-skin interaction.
C. Sinico (2005)
10.1016/J.IJPHARM.2006.06.034
Cytotoxic effect induced by retinoic acid loaded into galactosyl-sphingosine containing liposomes on human hepatoma cell lines.
C. Díaz (2006)
10.1016/0378-5173(95)04422-1
In vitro retinoic acid release and skin permeation from different liposome formulations
L. Montenegro (1996)
10.1038/sj.bjc.6604320
The rexinoid, bexarotene, prevents the development of premalignant lesions in MMTV-erbB2 mice
Y. Li (2008)
10.1016/J.EJPS.2007.01.002
N-phthaloylchitosan-g-mPEG design for all-trans retinoic acid-loaded polymeric micelles.
P. Opanasopit (2007)
10.1016/J.JCONREL.2004.07.032
Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powders.
Soo-Jeong Lim (2004)
10.1016/J.IJPHARM.2004.02.025
Phospholipid-based microemulsion formulation of all-trans-retinoic acid for parenteral administration.
S. R. Hwang (2004)
10.1182/BLOOD-2004-09-3437
Potential curability of newly diagnosed acute promyelocytic leukemia without use of chemotherapy: the example of liposomal all-trans retinoic acid.
E. Estey (2005)
10.1016/j.ijpharm.2008.06.028
Development of SLNs from natural lipids: application to topical delivery of tretinoin.
S. D. Mandawgade (2008)
A review of systemic retinoid therapy for acne and related conditions.
Kunynetz Ra (2004)
10.1016/S0378-5173(01)00971-1
Niosomes as carriers for tretinoin. I. Preparation and properties.
M. Manconi (2002)
10.1111/j.1468-3083.2004.00929.x
Improved efficacy and tolerability of retinoic acid in acne vulgaris: a new topical formulation with cyclodextrin complex ψ
R. Anadolu (2004)
10.1248/BPB.21.741
Targeting of soybean-derived sterylglucoside liposomes to liver tumors in rat and mouse models.
K. Shimizu (1998)
A randomized comparison of all trans retinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia
P Fenaux (1999)
10.1016/j.cell.2008.09.002
Retinoic Acid Synthesis and Signaling during Early Organogenesis
G. Duester (2008)
10.1111/J.1445-5994.1997.TB02213.X
Intravascular haemolysis complicating treatment of acute promyelocytic leukaemia with all-trans retinoic acid (ATRA)
C. Hogan (1997)
10.2147/CIIA.2006.1.4.327
Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety
S. Mukherjee (2006)
10.1016/J.MSEC.2005.09.052
Receptor-mediated delivery of all-trans-retinoic acid (ATRA) to hepatocytes from ATRA-loaded poly(N-p-vinylbenzyl-4-o-β-d-galactopyranosyl-d-gluconamide) nanoparticles
Seog Jin Seo (2006)
10.1111/J.1753-4887.2000.TB01851.X
Cellular retinoic acid-binding protein II: a coactivator of the transactivation by the retinoic acid receptor complex RAR.RXR.
G. Wolf (2000)
10.2174/157340707783220301
Innovative Drug Delivery Systems for the Administration of Natural Compounds
D. Paolino (2007)
Drug delivery systems.
H. P. Noteborn (1989)
Tumor-suppressive activity of retinoic acid receptor-beta in cancer.
X. Xu (2007)
10.1111/j.1529-8019.2006.00084.x
Update in retinoid therapy of acne
A. Thielitz (2006)
10.1016/S0378-5173(02)00245-4
Nebulization of niosomal all-trans-retinoic acid: an inexpensive alternative to conventional liposomes.
T. Desai (2002)
Retinoids: biological function and use in the treatment of dermatological diseases
MF Boehm (1995)
10.1016/S0731-7085(01)00502-7
Liposomes with tretinoin: a physical and chemical evaluation.
M. Brisaert (2001)
Pharmacokinetics of intravenously administered liposomal all-trans-retinoic acid (ATRA) and orally administered ATRA in healthy volunteers.
B. Ozpolat (2003)
10.1073/pnas.132657799
Adaptive immunity cooperates with liposomal all-trans-retinoic acid (ATRA) to facilitate long-term molecular remissions in mice with acute promyelocytic leukemia
P. Westervelt (2002)
10.1111/j.1440-1746.2006.04180.x
Antitumor effects of all‐trans‐retinoic acid on cultured human pancreatic cancer cells
J. Guo (2006)
10.1016/J.CANLET.2006.11.019
Tumor-suppressive activity of retinoic acid receptor-β in cancer
X. Xu (2007)
10.1182/BLOOD.V97.1.73
Treatment of newly diagnosed and relapsed acute promyelocytic leukemia with intravenous liposomal all-trans retinoic acid.
D. Douer (2001)
10.1016/J.EJPS.2005.01.021
Characterization of the 13-cis-retinoic acid/cyclodextrin inclusion complexes by phase solubility, photostability, physicochemical and computational analysis.
K. L. Yap (2005)



This paper is referenced by
10.1016/S1696-2818(11)70022-1
Actualización en acné
Fraile-Alonso María del carmen (2011)
10.1089/ten.TEA.2010.0463
Effects of retinoic acid on keratinocyte proliferation and differentiation in a psoriatic skin model.
Jessica Jean (2011)
TOPICAL AND SYSTEMIC DERMAL CARRIERS FOR PSORIASIS
R. Abdelgawad (2016)
10.5897/AJPPX12.001
Novel topical drug carriers as a tool for treatment of psoriasis: Progress and advances
P. Suresh (2013)
10.1016/j.ijpharm.2017.04.032
Enhanced anti-rheumatic activity of methotrexate-entrapped ultradeformable liposomal gel in adjuvant-induced arthritis rat model.
Alam Zeb (2017)
10.1016/j.xphs.2017.05.038
Mechanistic Analysis of Human Skin Distribution and Follicular Targeting of Adapalene-Loaded Biodegradable Nanospheres With an Insight Into Hydrogel Matrix Influence, In Vitro Skin Irritation, and In Vivo Tolerability.
M. Sallam (2017)
10.1002/cmdc.201600070
Cationic Supramolecular Vesicular Aggregates for Pulmonary Tissue Selective Delivery in Anticancer Therapy
M. Licciardi (2016)
10.3920/978-90-8686-729-5_8
8. Strategies for vitamin E transdermal delivery
Sonya Trombino (2012)
10.1016/j.ijpharm.2013.05.023
A retinyl palmitate-loaded solid lipid nanoparticle system: effect of surface modification with dicetyl phosphate on skin permeation in vitro and anti-wrinkle effect in vivo.
H. S. Jeon (2013)
Long-Acting Release Implants for Local Fenretinide Delivery and Oral Cancer Chemoprevention
Kari Nieto (2017)
10.1007/978-3-662-47862-2_2
Liposomes as Drug Delivery Systems in Dermal and Transdermal Drug Delivery
S. Šiler-Marinković (2016)
10.1016/S1773-2247(11)50064-4
Anticancer activity of 9-cis-retinoic acid encapsulated in PEG-coated PLGA-nanoparticles
D. Cosco (2011)
10.1016/j.imlet.2012.05.008
Retinal attenuates inflammatory arthritis by reciprocal regulation of IL-17-producing T cells and Foxp3(+) regulatory T cells and the inhibition of osteoclastogenesis.
M. Park (2012)
10.1016/j.ijpharm.2020.119475
Microencapsulation of Amorphous Solid Dispersions of Fenretinide Enhances Drug Solubility and Release from PLGA in vitro and in vivo.
K. Nieto (2020)
10.1159/000323012
Local Skin Pharmacokinetics of Talarozole, a New Retinoic Acid Metabolism-Blocking Agent
B. Baert (2011)
10.5151/CHEMENG-COBEQIC2017-356
ENCAPSULAÇÃO DE ÁCIDO RETINÓICO EM MICROEMULSÕES GELIFICADAS
S.G.M. Martins (2017)
10.1016/j.ijpharm.2011.03.068
Penetration enhancer containing vesicles as carriers for dermal delivery of tretinoin.
M. Manconi (2011)
TOPICAL AND SYSTEMIC DERMAL CARRIERS FOR PSORIASIS Review Article
R. Abdelgawad (2016)
10.1016/j.cis.2013.11.018
Niosomes from 80s to present: the state of the art.
C. Marianecci (2014)
10.1007/s00403-011-1166-4
Liposomal systems as drug delivery vehicles for dermal and transdermal applications
M. Pierre (2011)
10.1517/17425247.2015.1036738
New concepts to fight oxidative stress: nanosized three-dimensional supramolecular antioxidant assemblies
P. U. Richard (2015)
10.1016/j.xphs.2019.03.026
Comparison of Three Processes for Parenteral Nanoemulsion Production: Ultrasounds, Microfluidizer, and Premix Membrane Emulsification.
Océane Alliod (2019)
10.1201/B15642-3
Nanotechnology Applications in Dermatology
David Schairer (2013)
10.1016/B978-0-12-803269-5.00010-3
Antioxidant Polymers as Biomaterial
R. Lith (2016)
Developmental exposure to mixtures of persistent environmental pllutants with focus on bone and retinoid system modulations
Lubna E. Elabbas (2011)
10.1016/j.ejpb.2014.02.003
Encapsulation in lipid-core nanocapsules overcomes lung cancer cell resistance to tretinoin.
E. Schultze (2014)
10.1201/b14802-8
Nanodermatology: The Giant Role of Nanotechnology in Diagnosis and Treatment of Skin Disease
Adam J Friedman (2013)
10.1016/j.freeradbiomed.2015.07.149
Nitrite and nitrate-dependent generation of anti-inflammatory fatty acid nitroalkenes.
Meghan M Delmastro-Greenwood (2015)
10.2217/nnm.11.92
Nanocarriers for vascular delivery of antioxidants.
Elizabeth D Hood (2011)
10.1016/j.ijpharm.2014.10.031
Development of novel diolein-niosomes for cutaneous delivery of tretinoin: influence of formulation and in vitro assessment.
M. L. Manca (2014)
10.1016/J.JDDST.2015.10.011
Nanotherapeutics for anti-inflammatory delivery
L. D. Marzio (2016)
Semantic Scholar Logo Some data provided by SemanticScholar